Lower Hospitalization and Total Healthcare Costs Among Patients with Heart Failure When Treated with Sacubitril/Valsartan Versus Angiotensin-Converting Enzyme Inhibitor or Angiotensin-Receptor Blocker: A Retrospective Study of Managed Care Claims

Publication date: March–April 2020Source: Heart & Lung, Volume 49, Issue 2Author(s): Nancy Albert, Erin Buysman, Chunlan Chang, Jason Swindle
Source: Heart and Lung: The Journal of Acute and Critical Care - Category: Respiratory Medicine Source Type: research